![]() |
![]() |
|||||||||
|
How SeroCareSM Helpful information for people with SBS considering Zorbtive treatment Clinical information about Zorbtive for health professionals Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome Links
|
The links here may help you and your health professionals create a treatment program that moves you closer to some goals of treatment for Short Bowel Syndrome:
The provider of this web site takes no responsibility for the content or opinions expressed here. Medline Plus The Oley Foundation ASPEN American Dietetic Association American Gastroenterological Association The
Cleveland Clinic How SeroCareSM can help Zorbtive patients |
|||||||||
|
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed. Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling). Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications. This information is not intended to replace discussions with your healthcare professional. This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients This site contains medical information that is intended for residents of the United States © 2007 EMD Serono, Inc. All rights reserved.
|
||||||||||